X

Health Care

Jubilant Pharmova Limited (JUBLPHARMA ) Q3 FY23 Earnings Concall Transcript

Jubilant Pharmova Limited (NSE:JUBLPHARMA) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Vineet Mayer -- Investor Relations and Corporate Finance…

GMM Pfaudler Limited (GMMPFAUDLR) Q3 FY23 Earnings Concall Transcript

GMM Pfaudler Limited (NSE:GMMPFAUDLR) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Priyanka Daga -- Deputy General Manager Tarak Patel -- Managing…

Mahindra Lifespace Developers Limited (MAHLIFE) Q3 FY23 Earnings Concall Transcript

Mahindra Lifespace Developers Limited (NSE:MAHLIFE) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Arvind Subramanian -- Managing Director and Chief…

Max Healthcare Institute Ltd (MAXHEALTH) Q3 FY23 Earnings Concall Transcript

Max Healthcare Institute Ltd (NSE:MAXHEALTH) Q3 FY23 Earnings Concall dated Feb. 03, 2023.   Corporate Participants: Anoop Poojari -- Client Manager -…

Divi’s Laboratories Ltd (DIVISLAB) Q3 FY23 Earnings Concall Transcript

Divi's Laboratories Ltd (NSE: DIVISLAB) Q3 FY23 Earnings Concall dated Feb. 03, 2023 Corporate Participants: M. Satish Choudhury -- Company Secretary and…

Dr Lal PathLabs Ltd Q3 FY23 Earnings Conference Call Insights

Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q3 FY23 Earnings Concall Q&A Highlights: [00:12:28] Dheeresh Pathak from WhiteOak asked…

Zydus Lifesciences Q3FY23 net profit rises by 23%; Revenue soars 20%

Zydus Lifesciences Ltd reported a 23 per cent rise in consolidated net profit at INR 631 crore for the third…

Max Healthcare Q3FY23; 7% Growth in Profits

Max Healthcare Institute Ltd.’s gross revenue in Q3FY23 rose 13% to ₹ 1,559 crores. Consolidated Profit After Tax came at…

Alembic Pharmaceuticals Limited (APLLTD) Q3 FY23 Earnings Concall Transcript

Alembic Pharmaceuticals Limited (NSE:APLLTD) Q3 FY23 Earnings Concall dated Feb. 01, 2023. Corporate Participants: R.K. Baheti -- Director, Finance and Chief Financial…

Hester Biosciences Limited (HESTERBIO) Q3 FY23 Earnings Concall Transcript

Hester Biosciences Limited (NSE:HESTERBIO) Q3 FY23 Earnings Concall dated Jan. 31, 2023. Corporate Participants: Rajiv Gandhi -- Chief Executive Officer and Managing…